Thromboprophylaxis for COVID-19-related coagulopathy: what next?

Culic, Viktor; Vio, Riccardo; Proietti, Riccardo

Culic, Viktor; Vio, Riccardo; Proietti, Riccardo.

Culic V; Department of Cardiology and Angiology, University Hospital Centre Split, Soltanska 1, 21000 Split, Croatia.
Vio R; Department of Clinical Propedeutics, University of Split School of Medicine, Split, Croatia.
Proietti R; Cardiology Unit, Department of Cardiothoracic and Vascular Medicine, Ospedale dell'Angelo, Venice, Italy.

Eur Heart J Cardiovasc Pharmacother ; 8(3): E18-E19, 2022 05 05.

Article in English | MEDLINE | ID: covidwho-1662122

Subject(s)

COVID-19; Venous Thromboembolism; Anticoagulants/administration & dosage; Anticoagulants/adverse effects; Blood Coagulation; Humans; Randomized Controlled Trials as Topic; Venous Thromboembolism/diagnosis; Venous Thromboembolism/drug therapy; Venous Thromboembolism/prevention & control

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Venous Thromboembolism / COVID-19 Type of study: Diagnostic study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Eur Heart J Cardiovasc Pharmacother Year: 2022 Document Type: Article Affiliation country: Ehjcvp

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google